J U Igietseme, K H Ramsey, D M Magee, D M Williams, T J Kincy, R G Rank
{"title":"Resolution of murine chlamydial genital infection by the adoptive transfer of a biovar-specific, Th1 lymphocyte clone.","authors":"J U Igietseme, K H Ramsey, D M Magee, D M Williams, T J Kincy, R G Rank","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>MoPn-specific T-cell clones were isolated from a T-cell line that was capable of curing chlamydial genital infection by the Chlamydia trachomatis agent of mouse pneumonitis (MoPn) after adoptive transfer. Two clones (designated as 2.14-0 and 2.14-3) were characterized by flow cytometry techniques to be homogenous for L3T4, CD3, and alpha/beta T cell receptor (TcR) T-helper cell markers. The two clones were biovar specific, because they reacted to MoPn but not the Chlamydia psittaci agent of guinea pig inclusion conjunctivitis (GPIC) or C. trachomatis, serovar type E. Cytokine profile analysis, by a combination of bioassays, ELISA, and slot/Northern blotting for specific cytokine messenger RNAs, further revealed that cultures of antigen-stimulated clone 2.14-0 contained interleukin-2 (IL-2), tumor necrosis factor-alpha, and gamma interferon (a T helper 1 cell [Th1] profile). Clone 2.14-3 was also positive for gamma interferon, a level much lower than that of clone 2.14-0, and negative for IL-4 secretion, suggesting a Th1 profile as well. The ability of these clones to bring about the resolution of the chronic genital chlamydial infection of nude mice was tested by the adoptive transfer of 10(7) cells of each clone into the mice. By 4 weeks after cell transfer of clone 2.14-0, 81% of recipient nude mice (30 of 37) resolved the disease. In contrast, clone 2.14-3 or a control T-cell clone specific for a heterologous antigen were unable to resolve the infection in 20 recipients in each case, even after 100 days.(ABSTRACT TRUNCATED AT 250 WORDS)</p>","PeriodicalId":77348,"journal":{"name":"Regional immunology","volume":"5 6","pages":"317-24"},"PeriodicalIF":0.0,"publicationDate":"1993-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19062122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Effects of transforming growth factor beta on immunoglobulin production in cultured rat lacrimal gland tissue fragments.","authors":"D E Rafferty, P C Montgomery","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The effects of transforming growth factor-beta (TGF-beta) and TGF-beta in combination with selected interleukins (ILs) on immunoglobulin production was investigated using an in vitro rat lacrimal gland tissue-fragment culture system. TGF-beta alone or in combination with either IL-2, IL-5, IL-6, or IL-5 and IL-6 together significantly increased IgA levels over those obtained in untreated cultures. In all cases, IgA production was greater in cultures treated with TGF-beta in combination with these ILs than in cultures treated with TGF-beta or IL alone. The levels of IgG and IgM were generally not affected, with the exception of an enhancement noted in cultures treated with IL-5 and IL-6 or in combination with TGF-beta. These data indicate that TGF-beta can exert a stimulatory effect with IL-2, IL-5, IL-6, or IL-5 and IL-6 on IgA production in vitro and support a potential regulatory role for these cytokines in lacrimal gland IgA responses.</p>","PeriodicalId":77348,"journal":{"name":"Regional immunology","volume":"5 6","pages":"312-6"},"PeriodicalIF":0.0,"publicationDate":"1993-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19062119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
D M Magee, J U Igietseme, J G Smith, C A Bleicker, B G Grubbs, J Schachter, R G Rank, D M Williams
{"title":"Chlamydia trachomatis pneumonia in the severe combined immunodeficiency (SCID) mouse.","authors":"D M Magee, J U Igietseme, J G Smith, C A Bleicker, B G Grubbs, J Schachter, R G Rank, D M Williams","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>We have developed a model of pneumonia caused by the mouse pneumonitis agent (MoPn, murine Chlamydia trachomatis) in the C.B-17 severe combined immunodeficiency (SCID) mouse. In contrast to our prior models in the nude athymic (nu/nu) and heterozygous (nu/+) mouse, SCID mice lack B-cell function and gamma delta T-cell function. SCID mice were more susceptible to MoPn than nu/nu or nu/+ mice both by criteria of mortality and quantitative lung culture. SCID mice could be reconstituted with thymocytes to be more resistant to MoPn (in the absence of significant antibody production), but the protection was modest and less than that in T-cell reconstituted nu/nu mice in our previous studies. A nu/+ MoPn-specific T-cell clone with a Th1-like cytokine profile also provided modest but significant protection without significant antibody production. The SCID mouse is a useful model to study T-cell-mediated immunity to MoPn in a B cell and gamma delta T-cell-deficient environment.</p>","PeriodicalId":77348,"journal":{"name":"Regional immunology","volume":"5 6","pages":"305-11"},"PeriodicalIF":0.0,"publicationDate":"1993-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18528607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Characterization of neutrophils and T lymphocytes associated with the murine vaginal epithelium.","authors":"D Nandi, J P Allison","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The murine vaginal epithelium was investigated as a site for the presence of leukocytes, using monoclonal antibodies to various cell surface antigens in conjunction with multiparameter flow cytometry. Two types of CD45+ leukocytes were found with distinct expression of Mac-1 and CD3. The Mac-1+ cells are neutrophils, as evidenced by their multilobed nuclei. Previously, we have shown that alpha beta T cells, gamma delta T cells, and a novel population of Thy-1+CD3- cells are associated with the vaginal epithelium. In addition, a small number of MHC class II+ cells were detected. B cells, macrophages, and natural killer cells were not detected and do not contribute to the cellular immunity of the vagina. It is known that the lumen of the murine vagina is lined with stratified squamous epithelium, which undergoes marked changes during the estrous cycle. The cellular number and composition of dissociated epithelial associated Mac-1+ cells, alpha beta T cells, gamma delta T cells, and Thy-1+CD3- cells did not change significantly during the estrous cycle or under the influence of the ovarian hormones 17 beta-estradiol and progesterone. In summary, this study characterizes the leukocytes involved in mucosal immunity of the murine vagina.</p>","PeriodicalId":77348,"journal":{"name":"Regional immunology","volume":"5 6","pages":"332-8"},"PeriodicalIF":0.0,"publicationDate":"1993-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19062125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The kinetics of cytokine secretion and proliferation by mesenteric lymph node cells during the progression to murine AIDS, caused by LP-BM5 murine leukemia virus infection.","authors":"D S Huang, Y Wang, J J Marchalonis, R R Watson","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A murine acquired immunodeficiency syndrome (MAIDS) is induced in genetically susceptible strains of mice inoculated with LP-BM5 murine leukemia virus. It is characterized by progressive lymphoproliferation, profound immunodeficiency, and the subsequent loss of resistance to opportunistic pathogens, including intestinal pathogens. Cellular and/or humoral immunity of gut-associated lymphoid tissues may play a key role in the elimination of these pathogens. We have previously demonstrated reductions in the number of mucosal T and B cells in MAIDS. In this study, the cytokine production by mesenteric lymph nodes (MLN) cells and their proliferative response to mitogens during MAIDS were investigated. Alterations were observed in the kinetics of MLN cell proliferation and cytokine secretion by in vitro mitogen-stimulated MLN cells during the retrovirus infection. Cytokine production was abnormally changed, with a gradual decrease in interleukin-2 (IL-2) production as well as an increase in IL-5 and IL-6 secretion. Interferon-gamma production was increased during the progression to MAIDS. The dysregulated release of cytokines by MLN cells due to retrovirus infection could lead to immune dysfunction. These data indicate that dysregulated cytokine secretion by MLN cells may be responsible for impaired mucosal immunity in AIDS, explaining the dramatic increase of opportunistic intestinal pathogens in individuals with AIDS.</p>","PeriodicalId":77348,"journal":{"name":"Regional immunology","volume":"5 6","pages":"325-31"},"PeriodicalIF":0.0,"publicationDate":"1993-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19062124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Failure to inhibit endotoxin-induced uveitis with antibodies that neutralize tumor necrosis factor.","authors":"J T Rosenbaum, R S Boney","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Many of the effects of bacterial endotoxin are attributed to the cytokines that it induces. Tumor necrosis factor alpha (TNF alpha) may be responsible for many of the pathophysiologic effects of endotoxin because antibodies that neutralize TNF alpha reduce endotoxin-induced mortality in experimental animals and many of the activities of endotoxin can be mimicked by the infusion of TNF alpha. Accordingly, we tested the ability of an antibody that neutralizes TNF alpha in a well characterized rat model, endotoxin-induced uveitis. Rats receiving subcutaneous endotoxin had a prompt rise in serum TNF alpha that was eliminated by the monoclonal antibody. Small quantities of TNF alpha were detectable in aqueous humor after either subcutaneous or intravitreal injection of endotoxin. Endotoxin-induced uveitis as quantitated by cells and protein in aqueous humor was, however, not affected by the antibody. Similarly, intraocular inflammation was not reduced by the intravitreal injection of the neutralizing antibody. Although TNF alpha may mediate many of the systemic effects of endotoxin, its role in the intraocular inflammatory effects of endotoxin should be questioned.</p>","PeriodicalId":77348,"journal":{"name":"Regional immunology","volume":"5 5","pages":"299-303"},"PeriodicalIF":0.0,"publicationDate":"1993-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19139975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Murine Pam 212 cutaneous squamous cell carcinoma is nonimmunogenic in normal syngeneic hosts and resistant to immune effector mechanisms.","authors":"Z Chen, S I Rosten, E M Lord, A A Gaspari","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>We established a mouse model of cutaneous squamous cell carcinoma (SCC) using the Pam 212 cell line to study antitumor immunity in normal syngeneic hosts. In vitro, Pam 212 cells expressed very low levels of class I major histocompatibility complex (MHC) antigen; interferon-gamma (IFN-gamma) significantly increased the expression of this antigen. In vivo, Pam 212 tumors grew progressively in normal BALB/c hosts and resembled poorly differentiated human cutaneous SCC. Immunization of normal syngeneic hosts with irradiated, class I-negative or -positive Pam 212 cells failed to prevent tumor growth or induce specific cytotoxic T lymphocytes (CTL). However, Pam 212 tumor cells were rejected by C3H allogeneic mice, indicating adequate and functional class I antigen expression in vivo. Rejection of Pam 212 tumors by C3H hosts was in part dependent on CD8+ CTL lysis, as alloreactive anti-H-2d CTL lysed class I-positive Pam 212 cells, demonstrating that Pam 212 cells express functional class I MHC antigens. Both class I-positive and -negative Pam 212 cells were resistant to natural killer cell lysis. We hypothesize that ineffective syngeneic immune responses against Pam 212 cells may involve multiple mechanisms: inability of Pam 212 cells to elicit a primary immune response, as well as resistance to cell-mediated lysis.</p>","PeriodicalId":77348,"journal":{"name":"Regional immunology","volume":"5 5","pages":"285-92"},"PeriodicalIF":0.0,"publicationDate":"1993-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19140051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Tissue barriers, immunosuppressive microenvironments, and privileged sites: the eye's point of view.","authors":"J W Streilein","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Immune privilege exists at numerous sites in the body. It is becoming increasingly clear that privilege is extended to foreign tissues implanted at privileged sites by active regulatory mechanisms, rather than because implanted tissues are hidden from recognition by cells of the immune system. Recent experimental analysis of privilege has focused on regional tissue factors that participate in creating the privileged status. Local barriers are being more fully described, barriers that restrict, but do not prevent, afferent and efferent communication between a privileged site and the systemic immune apparatus. In addition, cytokines and mediators are being discovered at local sites, and these agents appear to create novel microenvironments that act on migrating cells of the lymphoreticular system and thereby modify both the induction and expression of immunity to antigenic materials that are introduced into, or arise within, privileged sites. This review summarizes many recent studies, and attempts to place in the broader context of systemic immunity what has been learned in the recent past about the unique forms of immunity that attend foreign tissue grafts and other types of antigenic materials placed experimentally in privileged sites. Particular emphasis is placed on reconciling (a) the requirements of various organs and tissues for immune protection against invading pathogens with (b) the vulnerability of certain organs and tissues to immunopathogenic processes that inadvertently inflict tissue injury and dysfunction.</p>","PeriodicalId":77348,"journal":{"name":"Regional immunology","volume":"5 5","pages":"253-68"},"PeriodicalIF":0.0,"publicationDate":"1993-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19140046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"In vitro culture allows splenic dendritic cells to reach their full potential for T-cell activation.","authors":"R Dai, J W Streilein","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Splenic dendritic cells (DCs), bone marrow-derived cells of the presumed monocyte/macrophage lineage, have been used as freshly prepared cells, as well as after overnight culture, to analyze their capacity to activate T cells in vitro with and without cognate antigen being present in the culture. Cultured DCs were found to possess potent accessory properties in vitro, displaying the abilities 1) to activate naive, syngeneic T cells in the absence of cognate antigen, and, after being derivatized with the hapten, dinitrofluorobenzene (DNFB), and 2) to sensitize unprimed, hapten-specific T cells such that the latter were able to mediate DNFB-dependent contact hypersensitivity in normal, unprimed mice. Freshly prepared splenic DCs also displayed accessory cell function; in the presence of the super-antigen, staphylococcal enterotoxin B, fresh DCs induced T-cell proliferation, and, when derivatized with DNFB, fresh DCs activated hapten-specific T cells from in vivo-primed mice. However, in both of these assays, fresh DCs were quantitatively inferior to cultured DCs. We conclude that splenic DCs can exist in two functional forms in vitro, and we propose that the functional properties displayed by freshly obtained cells correspond to the capabilities constitutively displayed by splenic DCs in the normal, unstimulated spleen. In these regards, splenic DCs appear to resemble Langerhans cells after the latter have been exposed to similar culture conditions. The possible relationships between Langerhans cells and DCs are discussed in terms of the role of the cytokine-containing microenvironment in dictating distinct functional properties of antigen-presenting cells.</p>","PeriodicalId":77348,"journal":{"name":"Regional immunology","volume":"5 5","pages":"269-78"},"PeriodicalIF":0.0,"publicationDate":"1993-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19140048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Aqueous humor inhibits epidermal cell antigen-presenting function.","authors":"J Hosoi, S Grabbe, T L Knisely, R D Granstein","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Aqueous humor (AH) is a complex biological fluid containing factors that mediate a number of activities that may contribute to immune privilege in the anterior chamber of the eye. To determine whether AH may inhibit dendritic cell antigen-presenting function, we evaluated the ability of AH to alter the ability of freshly obtained epidermal cell (EC) preparations enriched for Langerhans cells (LC) to present tumor-associated antigens (TAA) derived from the S1509a spindle cell tumor for elicitation of a delayed-type hypersensitivity (DTH) reaction in tumor-immune mice. Fresh EC preparations contain 2-5% LC. Exposure of EC to media containing AH for 2 hours prior to TAA-pulsing and injection into a hind footpad of tumor-immune mice resulted in a dose-dependent decrease in the DTH response. Aqueous humor contains transforming growth factor-beta (TGF beta), primarily TGF beta 2 as determined by specific neutralization of activity in the Mv 1 Lu cell assay. However, exposure of EC to TGF beta 2 in this fashion prior to TAA-pulsing had no effect on the degree of hypersensitivity elicited. Furthermore, preincubation of AH with neutralizing antiserum to TGF beta 2 had no effect on the ability of AH to inhibit LC antigen-presenting function. Mixing of AH-exposed non-TAA-pulsed EC with TAA-pulsed EC not exposed to AH prior to footpad challenge did not diminish the DTH response, suggesting that carryover of AH into the footpad was not responsible for the inhibition observed.(ABSTRACT TRUNCATED AT 250 WORDS)</p>","PeriodicalId":77348,"journal":{"name":"Regional immunology","volume":"5 5","pages":"279-84"},"PeriodicalIF":0.0,"publicationDate":"1993-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19140050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}